Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- befree-20150227 importedOn "2015-02-27" NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_assertion wasGeneratedBy ECO_0000203 NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_assertion wasDerivedFrom befree-20150227 NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_assertion SIO_000772 19143470 NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_assertion evidence source_evidence_literature NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.
- NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_assertion description "[Therapeutic efficacy of Ad-Flt3L and Ad-TK (+GCV) treatment was demonstrated in a second glioma model and in an intracranial melanoma model with concomitant increases in the levels of circulating HMGB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459587.RA5S-DjUpmETKFeNsC-DpGfUicAaaTb17_wcrWRZLrQ2c130_provenance.